KIR3DL1 and COVID-19: Despite the small sample size, the inhibitory KIR3DL1 gene was more prevalent in individual CHB (100%) than in COVID-19 (96%) and HIV-positive (92%) individuals and significantly higher than in healthy controls (p = 0.021, OR = ∞).